Cotecna Life Sciences India Private Limited, formerly Geo-Chem Pharma, has announced the inauguration of its new, state-of-the-art laboratory in Mumbai. This development represents a significant step in supporting the rapid growth of India’s pharmaceutical industry and demonstrates Cotecna’s dedication to fostering innovation, quality, and customer success.
The new facility, FDA-approved and NABL-accredited, is designed to meet the most stringent global standards for pharmaceutical testing and inspection. Equipped with cutting-edge technology, it offers tailored solutions to accelerate drug development, ensure compliance, and uphold the highest levels of quality control—key factors in helping pharmaceutical companies thrive in an increasingly competitive and regulated market.
Speaking on the occasion, Sebastien Dannaud, CEO at Cotecna Inspection, said, “This new laboratory marks a significant milestone in our mission to support India’s pharmaceutical sector. It highlights our commitment to driving quality, innovation, and efficiency in drug development. By combining advanced technology with the expertise of our global network—including SHIVA Labs in India and Neotron Pharma in Europe—we are dedicated to delivering safe and effective solutions to global markets.”
Leveraging its global network, Cotecna Life Sciences combines the expertise of Neotron Pharma, a premier European GMP analytical laboratory specialising in chemical and physical testing of APIs, drugs, and packaging, with SHIVA Labs in Bengaluru, known for its cGMP-compliant and USFDA-approved analytical services. Together, they provide comprehensive solutions such as impurity analysis, stability studies, and pharmacopeial testing, meeting the highest international standards.
Image caption- Sebastien Dannaud, CEO of Cotecna Inspection (right) and Amit Chopra CEO - South Asia Middle East, Cotecna (centre)inaugurat state-of-the-art laboratory in Mumbai
